Scancell Holdings (SCLP)


Latest News

A small-cap planning a breakout move

It's been a tough few weeks for the AIM market, but this minnow has shown some fight. Analyst Alistair Strang examines...

Trends and Targets for 20/02/2018

SCANCELL HOLDINGS (LSE:SCLP) For the n'th year running, the USA managed to surprise by sneaking in "Washingto...

Scancell to present at the Calculus Investor Forum

RNS Number: 0690F Scancell Holdings Plc 16 February 2018 16 February 2018 Scancell Holdings Plc ("Scancell" or the "Company") Scancell to present at the Calculus Investor Forum Scancell Holdings plc, ('Scancell' or the 'Company') the developer of novel immunotherapies for the treatment of cancer, announces that Cliff Holloway, Chief Executive Officer and Lind...

Scancell signs agreement with ISA Pharmaceuticals

Scancell, a developer of novel immunotherapies for the treatment of cancer, has signed a worldwide licensing and collabor...

All News

20-02-18A small-cap planning a breakout moveInteractive Investor
19-02-18Trends and Targets for 20/02/2018Trends and Targets
16-02-18Scancell to present at the Calculus Investor ForumRNS
15-02-18Scancell signs agreement with ISA PharmaceuticalsStockMarketWire
15-02-18Hardman Res. - Validating multiple opportunitiesRNS
15-02-18Collaboration agreement with ISA PharmaceuticalsRNS
12-02-18Scancell collects positive results from cancer treatment trialStockMarketWire
12-02-18Publication highlights potential of SCIB1 therapyRNS
11-02-18Trends and Targets for 12/02/2018Trends and Targets
09-02-18Scancell patent application for Moditope granted in EuropeStockMarketWire
09-02-18European patent application allowed for grantRNS
08-02-18Scancell member of team shortlisted for CRUK awardRNS
01-02-18Director/PDMR ShareholdingRNS
30-01-18Scancell Holdings losses widenStockMarketWire
30-01-18Half-year ReportRNS
09-01-18Scancell to collaborate with BioNTechRNS
14-12-17Scancell forms partnership with Cancer ResearchStockMarketWire
14-12-17Scancell and CRUK to advance cancer immunotherapyRNS
07-12-17Trends and Targets for 8/12/2017Trends and Targets
11-10-17Result of AGMRNS
10-10-17Directorate ChangeRNS
14-09-17Notice of AGMRNS
13-09-17Weak mining and consumer stocks hit FTSEStockMarketWire
13-09-17Scancell reports good progress in development of Modi-1StockMarketWire
13-09-17Final ResultsRNS
11-09-17Presents Moditope Data at Immunotherapy ConferenceRNS
29-08-17Oncimmune and Scancell Present Autoantibodies DataRNS
11-07-17Scancell notes continued progress on SCIB1StockMarketWire
11-07-17Continued Progress on SCIB1RNS
26-06-17Scancell notes ImmunoBody patent granted in EuropeStockMarketWire
26-06-17DNA ImmunoBody Patent Granted in EuropeRNS
22-05-17Holding(s) in CompanyRNS
19-05-17Holding(s) in CompanyRNS
19-05-17Holding(s) in CompanyRNS
11-05-17Results of PlacingRNS
11-05-17Scancell proposes raising up to £5.0mStockMarketWire
11-05-17Proposed Placing to Raise up to ?5.0 millionRNS
13-04-17Scancell changes registered officeStockMarketWire
13-04-17Change of Registered OfficeRNS
20-03-17Immuno-Oncology Summit Europe 2017RNS

RSS feeds

  • Editorial news feed for LSE:SCLP Editorial
  • Regulatory news feed for LSE:SCLP Regulatory